2 The rhizome of Atractylodes lancea (Thunb.) DC. (AL) is extensively used in 3 Chinese, Thai, and Japanese traditional medicines as crude extracts/decoctions or a 4 component in various herbal formulations. Various pharmacological activities of AL and 5 its major constituents have been demonstrated in vitro, ex vivo, and in animal models. 6 Results from the toxicity studies in animal models suggest safety profile of AL and its 7 active constituents. Despite extensive use with positive impression in many diseases, 8 there has not been a clinical study that can conclusively support its efficacy and safety 9 profile in human. This review comprehensively summarizes current information on the 10 pharmacological activities of AL and their active constituents including anticancer, anti-11 inflammatory, antimicrobial and antipyretic activities, as well as activities on central 12 nervous, cardiovascular, and gastrointestinal systems.
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this herb to its full therapeutic potential. This has brought about this review article, whose 48 purpose is to aid the readers in gaining a better understanding of the potential and toxicity 49 of this medicinal plant and to contribute to appropriate decision-making in further 50 development of AL. This review article will focus on the pharmacological activities of the 51 crude extract of AL rhizome including its major constituents: β-eudesmol, hinesol, 52 atractylone and atractylodin [7] [8] [9] . laboratory experiments and clinical trials [11] . Recently, it appears that the rhizome of AL 62 is a promising candidate herbal plant for further development as anticancer drugs, 63 particularly as an alternative treatment in patients with cholangiocarcionma (CCA), the 64 cancer of bile duct. 65 The anticancer activities of AL particularly anti-CCA have been demonstrated in 66 several studies both in vitro and in vivo. Of a total of 28 plants and 5 herbal formulations 67 used in Thai traditional medicine investigated for their cytotoxic activities, the crude 68 ethanolic extract of AL rhizome was shown to exhibit the most potent and selective 69 6 activity against CCA cell line (CL-6) with IC50 (concentration which inhibits cell growth by 70 50%) of 24.09±3.40 (mean±SD) µg/ml and SI (selectivity index) of 8.6 [12] . Results of the 71 in vitro screening of tumoricidal properties of international medicinal herbs conducted in 72 the United States also confirmed the anticancer activity of AL in murine neuroblastoma 73 cells originally derived from a spontaneous malignant tumor with moderate to strong 74 activity with LC50 (50% lethal concentration, the concentration which causes 50% cell 75 death) of 0.704 mg/ml [13] . These two studies have caught researchers' attentions to 76 further investigate the anticancer property of AL. Based on calcein-AM and Hoechst 77 33342 assays, the cytotoxic activity of the ethanolic extract of AL against CL-6 was found 78 to be more potent and more selective than the standard anticancer 5-fluorouracil (5-FU)
79
[14]. Additionally, AL also exhibited significant inhibitory effects on clonogenic survival, 80 tube formation, and invasion of CL-6 cells through a basement membrane model in a 81 dose-dependent manner.
However, this compound did not significantly exhibit 82 antioxidative activity determined by the radical-scarvenging activity of 2,2-diphenyl- was greater in diabetic than in normal muscles [24, 25] . Since it did not inhibit adrenaline/ADP-or adrenaline/5-HT-induced platelet aggregation, 153 its mechanism of action has been thought to be via suppression of collagen-induced 154 signal pathway, the upstream of the release of thromboxane A2 (TXA2) from platelets.
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Altogether, results suggest that care should be taken when using AL extract or its active 156 constituents in patients with platelet disorders or coagulopathy. The mechanisms of its action on these activities could be through either the inhibition of cyclooxygenase-1 (COX-1) with IC50 of 2.9 and 30.5 µg/ml, respectively [33] . Isolated 182 compound that exhibited potent inhibitory activities against both enzymes was shown to 183 be atractylochromene (IC50 for 5-LOX and COX-1 = 0.6 and 3.3 µM, respectively).
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Despite relatively low potency on COX-1 (IC50 = 64.3 µM), quinone, another isolated 185 compound, showed a selective inhibitory activity against 5-LOX (IC50 = 0.2 µM).
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Atractylone also exhibited inhibitory effects against 5-LOX but with potency about 100- AL, Atractylodes lancea; bFGF, basic fibroblast growth factor; VEGF, vascular endothelial growth factor; ERK, extracellular signal-regulated kinase; CREB, cyclic adenosine monophosphate (cAMP) response element binding protein; NMJ, neuromuscular junction; ACh, acetylcholine; TXA2, thromboxane A2; CRF,
